Zdrowie i gospodarka · 23/01/2003

FDA Announces Collection of Information for Adverse Experience Reporting

The Food and Drug Administration (FDA) is requesting public comment on a proposed collection of information related to adverse experience reporting for licensed biological products, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.